D1: Full Practice Authority
- Registration Closed
This presentation will review health policy basics at both the federal and state levels. Full practice authority and the varied state laws for nurse practitioner practice will be discussed. An exploration into political fundraising and grassroots advocacy along with examples will be presented.
Learning Objectives
After taking part in this educational activity, participants should be better able to:
- Define full practice authority (FPA) from a statutory and regulatory perspective
- Understand the practice barriers that exist beyond FPA
- Implement strategies to become engaged in the political process
Course Summary
| Live Date: | 8/31/2021 12:45pm - 8/31/2021 1:45pm ET |
| Course Expiration Date: | November 30, 2021 |
| Credits Offered: | 1.25 CE; includes 0.00 pharmacology credit |
Stephen A. Ferrera, DNP, FNP, FAANP, FAAN
Associate Dean, Clinical Affairs and Associate Professor, Columbia University School of Nursing
Executive Director, The Nurse Practitioner Association New York State
Dr. Stephen A. Ferrara is an actively practicing Nurse Practitioner, executive, and faculty member. He combines years of clinical experience along with health policy development to increase access to nurse practitioner-partnered care in New York State by serving as executive director of the Nurse Practitioner Association New York State. He is Associate Dean of Clinical Affairs and Associate Professor at Columbia University's School of Nursing where he leads the nurse practitioner primary care faculty practice. He is the interim executive director of Jonas Nursing and Veterans Healthcare.
Dr. Ferrara holds a passion for health care technology and integrating evidence-based practice into daily practice. His doctoral work examined the impact of group medical visits for patients with type II diabetes and how this intervention led to better health outcomes. Dr. Ferrara was a pioneer of healthcare blogging and authored, "A Nurse Practitioner's View," attracting thousands of readers by writing about issues, trends, and policies in health care. He has been nationally recognized for his work in health policy for increasing access to patient care across New York State.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.25 contact hours, of which 0.00 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Stephen A. Ferrera, DNP, FNP, FAANP, FAAN, have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
